These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 32467074)

  • 41. Neuropsychiatric Inventory in Community-Dwelling Older Adults with Mild Cognitive Impairment and Dementia.
    Nunes PV; Schwarzer MC; Leite REP; Ferretti-Rebustini REL; Pasqualucci CA; Nitrini R; Rodriguez RD; Nascimento CF; Oliveira KC; Grinberg LT; Jacob-Filho W; Lafer B; Suemoto CK
    J Alzheimers Dis; 2019; 68(2):669-678. PubMed ID: 30856109
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of cognitive impairment on fall risk among elderly nursing home residents.
    Seijo-Martinez M; Cancela JM; Ayán C; Varela S; Vila H
    Int Psychogeriatr; 2016 Dec; 28(12):1975-1987. PubMed ID: 27605458
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aerobic and strength training exercise programme for cognitive impairment in people with mild to moderate dementia: the DAPA RCT.
    Lamb SE; Mistry D; Alleyne S; Atherton N; Brown D; Copsey B; Dosanjh S; Finnegan S; Fordham B; Griffiths F; Hennings S; Khan I; Khan K; Lall R; Lyle S; Nichols V; Petrou S; Zeh P; Sheehan B
    Health Technol Assess; 2018 May; 22(28):1-202. PubMed ID: 29848412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study.
    Lyketsos CG; Lopez O; Jones B; Fitzpatrick AL; Breitner J; DeKosky S
    JAMA; 2002 Sep; 288(12):1475-83. PubMed ID: 12243634
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuropsychiatric symptoms in severe dementia: Associations with specific cognitive domains the Cache County Dementia Progression Study.
    Rozum WJ; Cooley B; Vernon E; Matyi J; Tschanz JT
    Int J Geriatr Psychiatry; 2019 Jul; 34(7):1087-1094. PubMed ID: 30945374
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiological characteristics and factors influencing falls among elderly adults in long-term care facilities in Xiamen, China.
    Zhang L; Zeng Y; Weng C; Yan J; Fang Y
    Medicine (Baltimore); 2019 Feb; 98(8):e14375. PubMed ID: 30813138
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cortical β-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic Study of Aging.
    Krell-Roesch J; Vassilaki M; Mielke MM; Kremers WK; Lowe VJ; Vemuri P; Machulda MM; Christianson TJ; Syrjanen JA; Stokin GB; Butler LM; Traber M; Jack CR; Knopman DS; Roberts RO; Petersen RC; Geda YE
    Transl Psychiatry; 2019 Mar; 9(1):123. PubMed ID: 30923322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sex differences in the severity of neuropsychiatric symptoms and their relationship with clinico-demographic and psychosocial factors in patients with amnestic mild cognitive impairment and mild Alzheimer's disease.
    Inamura K; Shinagawa S; Tsuneizumi Y; Nagata T; Tagai K; Nukariya K; Shigeta M
    Aging Ment Health; 2020 Mar; 24(3):431-438. PubMed ID: 30588827
    [No Abstract]   [Full Text] [Related]  

  • 49. Stability of the factor structure of the Neuropsychiatric Inventory in a 31-month follow-up study of a large sample of nursing-home patients with dementia.
    Selbæk G; Engedal K
    Int Psychogeriatr; 2012 Jan; 24(1):62-73. PubMed ID: 21682940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of agitation in long-term care residents with dementia in the United States.
    Fillit H; Aigbogun MS; Gagnon-Sanschagrin P; Cloutier M; Davidson M; Serra E; Guérin A; Baker RA; Houle CR; Grossberg G
    Int J Geriatr Psychiatry; 2021 Dec; 36(12):1959-1969. PubMed ID: 34286877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The individual course of neuropsychiatric symptoms in people with Alzheimer's and Lewy body dementia: 12-year longitudinal cohort study.
    Vik-Mo AO; Giil LM; Borda MG; Ballard C; Aarsland D
    Br J Psychiatry; 2020 Jan; 216(1):43-48. PubMed ID: 31506117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of small vessel disease and amyloid burden on neuropsychiatric symptoms: a study among patients with subcortical vascular cognitive impairments.
    Kim HJ; Kang SJ; Kim C; Kim GH; Jeon S; Lee JM; Oh SJ; Kim JS; Choe YS; Lee KH; Noh Y; Cho H; Yoon CW; Chin J; Cummings JL; Lee JH; Na DL; Seo SW
    Neurobiol Aging; 2013 Jul; 34(7):1913-20. PubMed ID: 23414669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuropsychiatric symptoms and functional status in Alzheimer's disease and vascular dementia patients.
    D'Onofrio G; Sancarlo D; Panza F; Copetti M; Cascavilla L; Paris F; Seripa D; Matera MG; Solfrizzi V; Pellegrini F; Pilotto A
    Curr Alzheimer Res; 2012 Jul; 9(6):759-71. PubMed ID: 22715983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessing Mild Behavioral Impairment with the Mild Behavioral Impairment-Checklist in People with Mild Cognitive Impairment.
    Mallo SC; Ismail Z; Pereiro AX; Facal D; Lojo-Seoane C; Campos-Magdaleno M; Juncos-Rabadán O
    J Alzheimers Dis; 2018; 66(1):83-95. PubMed ID: 30175974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease.
    Misquitta K; Dadar M; Louis Collins D; Tartaglia MC;
    Neuroimage Clin; 2020; 28():102367. PubMed ID: 32798911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of combined training on neuropsychiatric symptoms and quality of life in patients with cognitive decline.
    Cintoli S; Radicchi C; Noale M; Maggi S; Meucci G; Tognoni G; Bonuccelli U; Sale A; Berardi N; Maffei L;
    Aging Clin Exp Res; 2021 May; 33(5):1249-1257. PubMed ID: 31385203
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in Neuropsychiatric Inventory Associated with Semagacestat Treatment of Alzheimer's Disease.
    Rosenberg PB; Lanctôt KL; Herrmann N; Mintzer JE; Porsteinsson AP; Sun X; Raman R
    J Alzheimers Dis; 2016 Aug; 54(1):373-81. PubMed ID: 27567808
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognitive status is a determinant of health resource utilization among individuals with a history of falls: a 12-month prospective cohort study.
    Davis JC; Dian L; Khan KM; Bryan S; Marra CA; Hsu CL; Jacova P; Chiu BK; Liu-Ambrose T
    Osteoporos Int; 2016 Mar; 27(3):943-951. PubMed ID: 26449355
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modifiable factors associated with neuropsychiatric symptoms in nursing homes: The impact of unmet needs and psychotropic drugs.
    Ferreira AR; Simões MR; Moreira E; Guedes J; Fernandes L
    Arch Gerontol Geriatr; 2020; 86():103919. PubMed ID: 31525557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and characteristics of neuropsychiatric symptoms, quality of life and psychotropics in people with acquired brain injury in long-term care.
    Kohnen R; Lavrijsen J; Smals O; Gerritsen D; Koopmans R
    J Adv Nurs; 2019 Dec; 75(12):3715-3725. PubMed ID: 31318085
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.